OmniAb, Inc. (OABIW) stock
OABIWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/309% above fair value
$0.41−0.01 (-2.38%)
Close on Oct 30, 2026Market cap $742.95MP/E –Yield –
OmniAb price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
OmniAb's price to sales ratio was 17.7× on Oct 19, 2026, against 8.3× a year earlier. Over the last 5 years it ranged from 5.8× to 26.7×, with a median of 12.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 17.7× | +5.1 |
| 2025 | Dec 31, 2025 | 12.6× | −8.2 |
| 2024 | Dec 31, 2024 | 20.9× | +9.8 |
| 2023 | Dec 29, 2023 | 11.1× | +2.5 |
| 2022 | Dec 30, 2022 | 8.6× | – |